Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial Post author:Sam Post published:February 5, 2018 Post category:BioPharma The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace You Might Also Like Eton Pharma Appoints To Its Board Of Directors September 7, 2017 Pfizer Invites Public To Listen To Webcast Of April 27 Annual Meeting Of Shareholders April 20, 2017 <b>ISPE</b> Releases The New Cultural Excellence Report May 7, 2017
